The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

7 Nov 2019 13:47

RNS Number : 6874S
InnovaDerma PLC
07 November 2019
 

LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

 ("InnovaDerma" or the "Company")

Directorate Change

 

InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty and personal care products, today announces that Haris Chaudhry, the Executive Chairman, has informed the Board of his decision to leave the Company with immediate effect. Haris Chaudhry is departing for personal reasons and to pursue other interests.

 

The Board has agreed that with immediate effect, Haris Chaudhry will resign as Executive Chairman and relinquish his responsibilities but remain available to the Company to ensure the orderly handover and continued smooth running of the Life Sciences business, for which he had responsibility.

 

Joe Bayer, Finance Director and Executive Director of the Company, has been appointed Executive Chairman with immediate effect. Joe Bayer joined the Company as a Non-executive Director and an initial investor in 2014. In 2015 he was appointed Finance Director and Executive Director. Joe has more than three decades of international consumer and healthcare experience in senior executive positions. He will continue to oversee the finance function of the business and the Company will review the role of Finance Director and transition the role to a suitable candidate in due course. The Company currently has two non-executive directors and will look to broaden the board composition to ensure it has the right expertise and balance to maintain the continued success of the business and implement the next stage of growth.

 

As announced in the Company's trading statement yesterday, InnovaDerma continues to trade in line with market expectations. For the first four months of the new financial year, revenues were 38% higher compared with the same period last year, underpinned by strong performances across our topical brands and Prolong, both in retail stores and through our growing DTC channels. The Company will launch a new skin-care related category with Superdrug across all c.800 of its stores in H2 of FY 2020.

 

Joe Bayer, Executive Chairman of InnovaDerma, said:

 

"On behalf of the team at InnovaDerma, I would like to thank Haris for his deep commitment, leadership and contribution to the business over the years. It is his entrepreneurial spirit which founded the business and he took InnovaDerma from a pre-revenue to a multi-brand business. He leaves behind a company in the best shape it has ever been and at the forefront of several product categories. We wish him all the best for the future."

 

Haris Chaudhry, said:

 

"I am very proud of everything the team at InnovaDerma has achieved. Since I started the Company in 2013, the business has gone from strength to strength achieving profitable growth year after year. The business is maturing and I believe that the time is now right for me to pursue more entrepreneurial opportunities. I would like to thank the fantastic team at InnovaDerma and wish them the very best for the future."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries

 

InnovaDerma

Joe Bayer

Kieran Callan c/o TB Cardew

 

+61 (0)3 9863 8030

+44 (0)20 7930 0777

finnCap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane/Manasa Patil Ð Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser

 

+ 44 (0)20 7930 0777

innovaDerma@tbcardew.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFSMFDWFUSELF
Date   Source Headline
15th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSFinal Results
28th Sep 20207:00 amRNSUS distributor appointed and Nuthing launch in AUS
18th Sep 20207:00 amRNSNotice of Results and Presentation
1st Sep 20209:37 amRNSHolding(s) in Company
12th Aug 202010:58 amRNSHolding(s) in Company
5th Aug 20209:15 amRNSDirectorate Change
31st Jul 202010:22 amRNSHolding(s) in Company
13th Jul 20209:40 amRNSHolding(s) in Company
10th Jul 20207:00 amRNSTrading Statement
1st Jul 202010:10 amRNSHolding(s) in Company
12th Jun 20205:57 pmRNSHolding(s) in Company
26th May 20207:00 amRNSTrading Statement
13th May 20204:42 pmRNSHolding(s) in Company
7th May 202010:52 amRNSDirector/PDMR Shareholding
6th May 202010:05 amRNSHolding(s) in Company
4th May 202011:09 amRNSHolding(s) in Company
30th Apr 202011:05 amRNSSecond Price Monitoring Extn
30th Apr 202011:00 amRNSPrice Monitoring Extension
6th Apr 20202:05 pmRNSSecond Price Monitoring Extn
6th Apr 20202:00 pmRNSPrice Monitoring Extension
6th Apr 20207:00 amRNSCOVID-19 Update
23rd Mar 20207:00 amRNSDirector/PDMR Shareholding
18th Mar 20201:56 pmRNSDirector/PDMR Shareholding
17th Mar 20201:52 pmRNSHolding(s) in Company
16th Mar 202012:54 pmRNSDirector/PDMR Shareholding
12th Mar 20202:37 pmRNSDirector/PDMR Shareholding
12th Mar 202011:06 amRNSSecond Price Monitoring Extn
12th Mar 202011:00 amRNSPrice Monitoring Extension
3rd Mar 202010:47 amRNSDirector/PDMR Shareholding
25th Feb 202011:52 amRNSHalf-year Report- Replacement
25th Feb 20207:00 amRNSHalf-year Report
24th Feb 20207:00 amRNSInnovaDerma launches new brand "Nuthing"
3rd Feb 20207:00 amRNSNotice of Results
23rd Jan 20208:48 amRNSGrant of Options/PDMR Dealing
9th Jan 20207:00 amRNSTrading Statement
5th Dec 20197:00 amRNSDTC channel delivers best Black Friday weekend
29th Nov 20192:26 pmRNSDirector/PDMR Shareholding
28th Nov 20193:21 pmRNSDirector/PDMR Shareholding
20th Nov 20197:00 amRNSLaunch of new Skinny Tan 'Choc' range in Superdrug
13th Nov 201912:39 pmRNSDirector/PDMR Shareholding
8th Nov 20193:40 pmRNSDirector/PDMR Shareholding
8th Nov 20193:22 pmRNSDirector/PDMR Shareholding
7th Nov 20192:33 pmRNSHolding(s) in Company
7th Nov 20191:55 pmRNSHolding(s) in Company
7th Nov 20191:53 pmRNSDirector/PDMR Shareholding
7th Nov 20191:47 pmRNSDirectorate Change
6th Nov 201911:01 amRNSResult of AGM
6th Nov 20197:00 amRNSAGM Statement
31st Oct 20197:00 amRNSLaunch of new category in Superdrug

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.